Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men

AIDS

Volumn 26, Issue 2, 2012, Pages 157-165

  Pacold, Mary E ^a   Pond, Sergei L Kosakovsky ^b   Wagner, Gabriel A ^b   Delport, Wayne ^b   Bourque, Daniel L ^b   Richman, Douglas D ^b,c   Little, Susan J ^b   Smith, Davey M ^b,c  

^a Stanford University ^*  (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

CD4 cell count; cytotoxic T lymphocyte; HIV 1 dual infection; HLA; viral load

Indexed keywords

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLADISTICS; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL; SUPERINFECTION; VIRUS LOAD;

ADULT; ALGORITHMS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RNA, VIRAL; SUPERINFECTION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; YOUNG ADULT;

EID: 84155162517     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834dcd26     Document Type: Article

References (43)

1. McCutchan FE. Global epidemiology of HIV. J Med Virol 2006; 78 (Suppl 1):S7-S12.
2. Smith D, Richman D, Little S. HIV superinfection. J Infect Dis 2005; 192:438-444.
3. Artenstein A, VanCott T, Mascola J, Carr J, Hegerich P, Gaywee J, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995; 171:805-810.
4. Diaz R, Sabino E, Mayer A, Mosley J, Busch M. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol 1995; 69:3273-3281.
5. Pieniazek D, Janini LM, Ramos A, Tanuri A, Schechter M, Peralta JM, et al. HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. Emerging Infect Dis 1995; 1:86-88.
6. Sala M, Pelletier E, Wain-Hobson S. HIV-1 gp120 sequences from a doubly infected drug user. AIDS Res Hum Retroviruses 1995; 11:653-655.
7. Sala M, Zambruno G, Vartanian J, Marconi A, Bertazzoni U, Wain-Hobson S. Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol 1994; 68:5280-5283.
8. Xin KQ, Ma XH, Crandall KA, Bukawa H, Ishigatsubo Y, Kawamoto S, Okuda K. Dual infection with HIV-1 Thai subtype B and E. Lancet 1995; 346:1372-1373.
9. Zhu T, Wang N, Carr A, Wolinsky S, Ho D. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J Virol 1995; 69:1324-1327.
10. Gottlieb G, Nickle D, Jensen M, Wong K, Grobler J, Li F, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet 2004; 363:619-622.
11. Altfeld M, Allen T, Yu X, Johnston M, Agrawal D, Korber B, et al. HIV-1 superinfection despite broad CD8R T-cell responses containing replication of the primary virus. Nature 2002; 420:434-439.
12. Jost S, Bernard M, Kaiser L, Yerly S, Hirschel B, Samri A, et al. A patient with HIV-1 superinfection. N Engl J Med 2002; 347:731-736.
13. Smith D, Wong J, Hightower G, Ignacio C, Koelsch K, Daar E, et al. Incidence of HIV superinfection following primary infection. JAMA 2004; 292:1177-1178.
14. Piantadosi A, Ngayo M, Chohan B, Overbaugh J. Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses 2008; 24:1221.
15. Yerly S, Jost S, Monnat M, Telenti A, Cavassini M, Chave J, et al. HIV-1 co/super-infection in intravenous drug users. AIDS 2004; 18:1413-1421.
16. Smith D, Strain M, Frost S, Pillai S, Wong J, Wrin T, et al. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology 2006; 355:1-5.
17. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, et al. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med 2008; 14:413-420.
18. Pacold M, Smith D, Little S, Cheng PM, Jordan P, Ignacio C, et al. Comparison of methods to detect HIV dual infection. AIDS Res Hum Retroviruses 2010; 26:1291-1298.
19. Pond S, Frost S, Muse S. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005; 21:676-679.
20. Gianella S, Delport W, Pacold ME, Young JA, Choi JY, Little SJ, et al. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J Virol 2011; 85:8359-8367.
21. Kosakovsky Pond SL, Posada D, Stawiski E, Chappey C, Poon AFY, Hughes G, et al. An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol 2009; 5:e1000581.
22. Chow G. Tests of equality between sets of coefficients in two linear regressions. Econometrica J Econometric Soc 1960; 28:591-605.
23. Kosakovsky Pond S, Posada D, Gravenor M, Woelk C, Frost S. GARD: a genetic algorithm for recombination detection. Bioinformatics 2006; 22:3096-3098.
24. Tavare S. Some probabilistic and statistical problems in the analysis of DNA sequences. In American Mathematical Society: lectures on mathematics in the life sciences: Am Mathematical Soc 1986; 57-86.
25. Scheffler K, Martin DP, Seoighe C. Robust inference of positive selection from recombining coding sequences. Bioinformatics (Oxford, England) 2006; 22:2493-2499.
26. Hoelscher M, Dowling W, Sanders-Buell E, Carr J, Harris M, Thomschke A, et al. Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multiregion hybridization assay. AIDS 2002; 16:2055-2064.
27. Kijak G, McCutchan F. HIV diversity, molecular epidemiology, and the role of recombination. Curr Infect Dis Rep 2005; 7: 480-488.
28. Kishino H, Hasegawa M. Evaluation of the maximumlikelihood estimate of the evolutionary tree topologies from DNA sequence data, and the branching order in hominoidea. J Mol Evol 1989; 29:170-179.
29. Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, et al. Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol 2010; 84:2610-2617.
30. Tang J, Malhotra R, Song W, Brill I, Hu L, Farmer PK, et al. Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS ONE 2010; 5:e9629.
31. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E, et al. Advantage of rare HLA supertype in HIV disease progression. Nature Med 2003; 9:928-935.
32. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, et al. HLA and HIV-1: heterozygote advantage and B35-Cw04 disadvantage. Science 1999; 283:1748-1752.
33. Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, et al. Human immunodeficiency virus type 1-specific CD8R Tcell responses during primary infection are major determinants of the viral set point and loss of CD4R T cells. J Virol 2009; 83:7641-7648.
34. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001; 344:1668-1675.
35. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007; 68:779-788.
36. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 2003; 61:403-407.
37. Butler IF, Pandrea I, Marx PA, Apetrei C. HIV genetic diversity: biological and public health consequences. Curr HIV Res 2007; 5:23-45.
38. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virusspecific CD8R cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-6110.
39. Cao J, McNevin J, Malhotra U, McElrath MJ. Evolution of CD8R T cell immunity and viral escape following acute HIV-1 infection. J Immunol 2003; 171:3837-3846.
40. Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8R T cells in primary HIV-1 infection. J Virol 2003; 77:6867-6878.
41. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-4655.
42. Oxenius A, Price DA, Trkola A, Edwards C, Gostick E, Zhang H-T, et al. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8R T cell responses and decrease in HIV-1-specific CD4R and CD8R T cell frequencies. J Infect Dis 2004; 190:713-721.
43. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8R T cells after early HIV-1 infection. J Virol 2007; 81:4199-4214.